Trade Mark Journal No.2026/026 26 June 2026

UK00004401607 12 June 2026 (35,36,44)

ONPATH WITH OTARMENI

International priority date claimed: 22 December 2025 (United States of America) (99562098)
Class 35
Business administration services, namely, business administration of a program to provide access to medicines at low or no cost to underserved populations; Business administration services, namely, business administration of a program to provide discounts on prescription medicines.
Class 36
Financial administration services, namely, financial administration of a program to provide access to medicines at low or no cost to underserved populations; Financial administration services, namely, financial administration of a program to provide discounts on prescription medicines.
Class 44
Medical assistance services in the field of treatment of auditory and neurological diseases and disorders; Providing medical information regarding diagnosis and treatment of auditory and neurological diseases and disorders.

Regeneron Pharmaceuticals, Inc.

Representative: Appleyard Lees IP LLP